In Gainesville, Biopharma Finds a Place in the Sun
Florida Region Has a Top-Tier Incubator, Recognized Schools, and Growing Companies
The Future Is Fluid
Liquid Biopsy Has Proven Its Mettle in the Fight against NSCLC and May Soon Also Be Standard of Care in Other Cancers
Genomics Brings Heavy Lifting to Immuno-Oncology
The Synergy of Two Burgeoning Fields Will Lead to Improved Precision Medicine
Singling Out RNA Biomarkers in Situ
ACD’s ISH Platform Achieves Single-Base Resolution and Retains Morphological Context
- Headquarters, 13962 Pierce Rd.
- Saratoga CA, 95070
- UNITED STATES
Cellworks has built a pipeline of drug candidates for cancer and rheumatoid arthritis by implementing a novel approach to therapeutic design and development. The Cellworks approach combines a predictive and responsive network of protein interactions with sophisticated algorithms to emulate human physiology and predict clinical outcomes early on. The company is using this technology to design novel mechanism of actions by combining existing FDA approved drugs that work synergistically to impact multiple disease pathways simultaneously.